Eli Lilly and Company (LLY) vs Pfizer Inc. (PFE)
LLY leads on 9 of 16 compared metrics, though PFE is the cheaper stock.
A side-by-side comparison of Eli Lilly and Company and Pfizer Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — LLY vs PFE
growth of $100 · last 30yLLY +3454.0%PFE +128.5%LLY compounded faster
Log scale — wide-divergence pair
LLY PFE
LLY vs PFE: by the numbers
- •LLY is the larger company ($1.07T vs $149.38B market cap).
- •PFE trades at the lower earnings multiple (20.01 vs 40.25 P/E).
- •LLY converts more revenue to profit (34.98% vs 11.83% net margin).
- •LLY grew revenue faster over the past five years (23.17% vs 8.22% CAGR).
- •PFE pays the higher dividend yield (6.56% vs 0.57%).
Which is better, LLY or PFE?
Metric tally: LLY 9 · PFE 7It depends on what you're optimizing for:
ValuePFE(lower P/E)
GrowthLLY(faster 5Y revenue CAGR)
IncomePFE(higher dividend yield)
QualityLLY(higher ROIC)
Valuation
| Metric | LLY | PFE |
|---|---|---|
| P/E ratio | 40.25 | 20.01● |
| Forward P/E | 25.41 | 9.25● |
| P/S ratio | 14.05 | 2.37● |
| P/B ratio | 32.54 | 1.67● |
| PEG ratio | 0.49 | — |
| EV / EBITDA | 31.47 | 12.72● |
| FCF yield | 1.34% | 6.31%● |
Profitability
| Metric | LLY | PFE |
|---|---|---|
| Gross margin | 83.51%● | 69.35% |
| Operating margin | 45.87%● | 23.45% |
| Net margin | 34.98%● | 11.83% |
| ROE | 81.01%● | 8.31% |
| ROIC | 30.20%● | 8.84% |
Dividends
| Metric | LLY | PFE |
|---|---|---|
| Dividend yield | 0.57% | 6.56%● |
| Payout ratio | 28.09% | 126.47% |
Growth (annualized)
| Metric | LLY | PFE |
|---|---|---|
| Revenue CAGR (5Y) | 23.17%● | 8.22% |
| EPS CAGR (5Y) | 28.88%● | -3.78% |
| FCF CAGR (5Y) | 19.54%● | -3.79% |
| Total return CAGR (5Y) | 39.57%● | -3.33% |
Frequently asked
- Which is better, LLY or PFE?
- It depends on your goal. value: PFE (lower P/E); growth: LLY (faster 5Y revenue CAGR); income: PFE (higher dividend yield); quality: LLY (higher ROIC). Across all compared metrics, LLY leads 9 to 7.
- Is LLY or PFE cheaper?
- On trailing earnings, PFE is cheaper: LLY trades at a 40.25 P/E and PFE at 20.01.
- Which has grown faster, LLY or PFE?
- Over the past five years, LLY grew revenue faster — LLY at a 23.17% CAGR versus PFE at 8.22%.
- Does LLY or PFE pay a bigger dividend?
- LLY yields 0.57% and PFE yields 6.56% based on trailing dividends and the latest price.
- Is LLY or PFE more profitable?
- LLY runs the higher net margin — LLY at 34.98% versus PFE at 11.83%.
- Which has been the better investment, LLY or PFE?
- Over the past 10-year, LLY delivered the higher annualized total return — LLY at 33.50% versus PFE at 2.13%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Eli Lilly and P/E ratioPfizer P/E ratioEli Lilly and dividend yieldPfizer dividend yieldEli Lilly and ROEPfizer ROEEli Lilly and operating marginPfizer operating marginEli Lilly and revenue growthPfizer revenue growthEli Lilly and free cash flowPfizer free cash flow
Eli Lilly and & Pfizer appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.